Methods and formulations for use in treating oophorectomized women |
| OF THE INVENTION Pursuant to the present invention, the regimen comprises a slow-release (or depot)... |
|
Treatment of sexual dysfunction in certain patient groups |
| OF THE INVENTION The present invention relates to methods for the treatment of sexual dysfunction ... |
|
Treatment of sexual dysfunction in certain patient groups |
| OF THE INVENTION The present invention relates to methods for the treatment of sexual dysfunction ... |
|
Oil composition |
| What is claimed is: 1. An oil composition, comprising about 0.1 to 59.8% by weight of a ... |
|
Blocking agents of EDRF effect or formation for the treatment of shock |
| We claim: 1. A therapeutical composition of matter for the treatment by perfusion of shock states ... |
|
Use of polyamines as ionic-channel regulating agents |
| OF THE PREFERRED EMBODIMENTS The disclosure of any and all cited documents including literature ... |
|
Inhibitor of ceramidase |
| It is a general object of the invention to provide a method of selecting compounds that cause ... |
|
Treatment of bone disorders with adrenomedullin |
| OF THE INVENTION It is believed that one skilled in the art can, based on the description herein, ... |
|
|
Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses
| Details |
Inventors: Garvey, David S.; Schroeder, Joseph D.; Saenz de Tejada, Inigo;
Assignee: NitroMed, Inc. (Bedford, MA)
Primary Examiner: Tsang; Cecilia J.
Assistant Examiner: Celsa; Bennett
Attorney, Agent or Firm: Hale and Dorr LLP
Disclosed are nitrosated and nitrosylated .alpha.-adrenergic receptor antagonists, compositions of an .alpha.-adrenergic receptor antagonist (.alpha.-antagonist), which can optionally be substituted with at least one NO or NO.sub.2 moiety, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO.sup.+) or nitroxyl (NO.sup.-), or as the neutral species, nitric oxide (NO.circle-solid.); and uses for each of them in treating human male impotence or erectile dysfunction. |
|
DETAILED DESCRIPTION OF THE INVENTION The term "lower alkyl" as used herein refers to branched or straight chain alkyl groups comprising one to ten carbon atoms, including methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl, neopentyl and the like. The term "alkoxy" as used herein refers to R. sub. 50 O-wherein R. sub. 50 is lower alkyl as defined above. Representative examples of alkoxy groups include methoxy, ethoxy, t-butoxy and the like. The term "alkoxyalkyl" as used herein refers to an alkoxy group as previously defined appended to an alkyl group as previously defined. Examples of alkoxyalkyl include, but are not limited to, methoxymethyl, methoxyethyl, isopropoxymethyl and the like. The term "hydroxy" as used herein refers to --OH. The term "hydroxyalkyl" as used herein refers to a hydroxy group as previously defined appended to an alkyl group as previously defined. The term "alkenyl" as used herein refers to a branched or straight chain C. sub. 2 -C. sub. 10 hydrocarbon which also comprises one or more carbon-carbon double bonds. The term "amino" as used herein refers to --NH. sub. 2. The term "nitrate" as used herein refers to --O--NO. sub. 2. The term "alkylamino" as used herein refers to R. sub. 11 NH-- wherein R. sub. 11 is a lower alkyl group, for example, methylamino, ethylamino, butylamino, and the like. The term "dialkylamino" as used herein refers to R. sub. 12 R. sub. 13 N-- wherein R. sub. 2 and R. sub. 13 are independently selected from lower alkyl, for example dimethylamino, diethylamino, methyl propylamino and the like. The term "nitro" as used herein refers to the group --NO. sub. 2 and "nitrosated" refers to compounds that have been substituted therewith. The term "nitroso" as used herein refers to the group --NO and "nitrosylated" refers to compounds that have been substituted therewith. The term "aryl" as used herein refers to a mono- or bicyclic carbocyclic ring system having one or two aromatic rings including, but not limited to, phenyl, naphthyl, tetrahydronaphthyl, indanyl, indenyl, and the like
|
| Related patents |
|
|
Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
What is claimed is: 1. A compound having the formula I ##STR39## wherein: A represents sulfur or selenium; Z represents a substituted or unsubstituted mono- or fused or ...
|
|
|
Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same
What is claimed is: 1. An injectable solution suitable for the embolization of microspheres, which comprises a microsphere having a diameter ranging between about 10 to ...
|
|
|
Therapeutic system for dietary health management
In light of the above described need, it is an object of the present invention to provide a dietary health management system which adequately supplies desired levels of ...
|
|
|
Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
What is claimed is: 1. A composition, which comprises: a) propionyl L-carnitine or a pharmacologically acceptable salt thereof; and b) 4',5,7-trihydroxyisoflavone, each ...
|
|
|
Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor
What is claimed is: 1. A pharmaceutical composition containing a combination of 10-360 mg of diltiazem and 1-100 mg of an angiotensin-converting enzyme inhibitor, ...
|
|
|
1-bolizazepin-2,5-diones
What we claim is: 1. A method for the treatment of stroke, hypoglycemia, ischemic attack or anoxia comprising administering to a mammal in need of such treatment an ...
|
|
|
Fungicidal compositions and methods for production thereof
What is claimed is: 1. A particulate composition comprising one or more components selected from dithiocarbamates and bisdithiocarbamoyl disulfides and a moisture ...
|
|
|
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
OF THE INVENTION The invention described herein is directed to pharmaceutical compositions that provide for the controlled release of an active ingredient in the ...
|
|
|
Dispersion polymers for ethylene quench water clarification
We claim: 1. A method of removing emulsified oil from ethylene quench water, the method comprising the step of treating the oil-containing water with an effective amount ...
|
|
|
Corneal angiogenesis inhibitor
What is claimed is: 1. A method for treating corneal neovasculariztion which comprises: administering an effective amount of interferon .beta. for treating corneal ...
|
|
|